BIIB

This Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday

BIIB's Next-Gen SMA Therapy Salanersen Wins FDA's Breakthrough Tag

BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm

Biogen's Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses